NCT06152471 2023-11-30
ASF-BC
Uppsala University Hospital
Phase 3 Unknown
Clinical Trials
13 trialsNCT00003057 2023-06-18
Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related Diarrhea in Patients With Colorectal Cancer
Eastern Cooperative Oncology Group
Phase 3 Completed
NCT00444093 2023-05-11
Loop
Philipps University Marburg
Phase 3 Terminated
NCT02819960 2022-12-14
Prevention of Irinotecan Induced Diarrhea by Probiotics
S&D Pharma SK s.r.o.
Phase 3 Completed
NCT00774930 2022-10-14
ELECT
Ipsen
Phase 3 Completed
NCT01371656 2020-12-07
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
Children's Oncology Group
Phase 3 Completed
NCT01198145 2020-05-12
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00033605 2016-07-13
Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT01473290 2016-07-06
Probiotic Therapy in Preventing Gastrointestinal Complications in Patients Undergoing Chemotherapy and Pelvic Radiation Therapy
Alliance for Clinical Trials in Oncology
Phase 3 Withdrawn
NCT00582426 2015-05-04
LARCID
Novartis
Phase 3 Completed
NCT01410955 2014-01-23
Prevention of Irinotecan Induced Diarrhea by Probiotics
Monsea Ltd.
Phase 3 Completed
NCT01839721 2013-05-17
Impact of Probiotics BIFILACT® on Diarrhea in Patients Treated With Pelvic Radiation
CHU de Quebec-Universite Laval
Phase 3 Completed
NCT00006269 2012-05-25
Octreotide in the Prevention of Diarrhea in Patients Receiving Irinotecan for Metastatic Colon Cancer
Novartis
Phase 3 Terminated